51job, Inc. (JOBS) Reports Q4 EPS of $0.91

51job, Inc. (NASDAQ: JOBS) reported Q4 EPS of $0.91. Revenue for the quarter came in at $163.12 million.

Fourth Quarter 2019 Financial Highlights:

• Net revenues increased 1.3% over Q4 2018 to RMB1,135.6 million (US$163.1 million)
• Online recruitment services revenues decreased 5.0%
• Other human resource related revenues increased 10.0%
• Income from operations was RMB395.3 million (US$56.8 million)
• Fully diluted earnings per share was RMB3.67 (US$0.53)
• Excluding share-based compensation expense, loss from foreign currency translation, change in fair value of equity securities investment and impairment of long-term investments, as well as the related tax effect of these items, non-GAAP adjusted fully diluted earnings per share was RMB6.33 (US$0.91)

Commenting on the results, Rick Yan, President and Chief Executive Officer of 51job, said, "Through disciplined execution of our strategic plan in a year of high economic uncertainty and tough market conditions, we are pleased to have maintained growth and delivered profitable returns in 2019. We continued to uplift average spending by employers on our many online recruitment platforms and to improve cross-selling of other HR services to the customer base. We also further expanded 51job's HR ecosystem with more products, technologies and partners that we believe bring exciting new monetization opportunities and enhance our growth trajectory over the long term. Although the impact of the coronavirus outbreak has led to a disruptive start to 2020 and significantly affected current visibility, our solid business fundamentals and ample financial resources will enable us to navigate through this challenging period, and we will continue to push forward with initiatives that strengthen our competitiveness and leadership in the HR industry for the future."

For earnings history and earnings-related data on 51job, Inc. (JOBS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Movano (MOVE) Misses Q2 EPS by 195c